Venus Medtech Hangzhou Inc
HKEX:2500
Income Statement
Earnings Waterfall
Venus Medtech Hangzhou Inc
Revenue
|
491.4m
CNY
|
Cost of Revenue
|
-102.2m
CNY
|
Gross Profit
|
389.2m
CNY
|
Operating Expenses
|
-1.1B
CNY
|
Operating Income
|
-677.4m
CNY
|
Other Expenses
|
-43.5m
CNY
|
Net Income
|
-720.9m
CNY
|
Income Statement
Venus Medtech Hangzhou Inc
Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|
Revenue | ||||||
Revenue |
416
N/A
|
387
-7%
|
406
+5%
|
452
+11%
|
491
+9%
|
|
Gross Profit | ||||||
Cost of Revenue |
(92)
|
(86)
|
(92)
|
(101)
|
(102)
|
|
Gross Profit |
324
N/A
|
300
-7%
|
314
+5%
|
351
+12%
|
389
+11%
|
|
Operating Income | ||||||
Operating Expenses |
(745)
|
(768)
|
(1 506)
|
(1 568)
|
(1 067)
|
|
Selling, General & Administrative |
(345)
|
(383)
|
(453)
|
(520)
|
(459)
|
|
Research & Development |
(258)
|
(331)
|
(453)
|
(535)
|
(447)
|
|
Depreciation & Amortization |
0
|
(43)
|
(75)
|
(67)
|
(78)
|
|
Other Operating Expenses |
(142)
|
(11)
|
(526)
|
(446)
|
(83)
|
|
Operating Income |
(420)
N/A
|
(468)
-11%
|
(1 192)
-155%
|
(1 217)
-2%
|
(677)
+44%
|
|
Pre-Tax Income | ||||||
Interest Income Expense |
46
|
(39)
|
58
|
(64)
|
(75)
|
|
Non-Reccuring Items |
(3)
|
0
|
(22)
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(378)
N/A
|
(507)
-34%
|
(1 156)
-128%
|
(1 280)
-11%
|
(752)
+41%
|
|
Net Income | ||||||
Tax Provision |
6
|
13
|
34
|
32
|
6
|
|
Income from Continuing Operations |
(371)
|
(494)
|
(1 122)
|
(1 249)
|
(746)
|
|
Income to Minority Interest |
(2)
|
33
|
64
|
41
|
25
|
|
Net Income (Common) |
(374)
N/A
|
(461)
-23%
|
(1 058)
-130%
|
(1 208)
-14%
|
(721)
+40%
|
|
EPS (Diluted) |
-0.85
N/A
|
-1.05
-24%
|
-2.42
-130%
|
-2.75
-14%
|
-1.65
+40%
|